These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 30173781)

  • 21. [Preoperative prognostic factors and preoperative risk stratification of upper tract urothelial carcinoma].
    Xing YC; Xiong GY; Fang D; Zhang Z; Cai L; Zhang L; He ZS; Li XS; Zhou LQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1032-1037. PubMed ID: 27987509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing Changes in Renal Function After Radical Surgery for Upper Tract Urothelial Carcinoma and Renal Cell Carcinoma.
    Singla N; Hutchinson R; Menegaz C; Haddad AQ; Jiang L; Sagalowsky AI; Cadeddu JA; Lotan Y; Margulis V
    Urology; 2016 Oct; 96():44-53. PubMed ID: 27443467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive factors for worse pathological outcomes of upper tract urothelial carcinoma: experience from a nationwide high-volume centre in China.
    Chen XP; Xiong GY; Li XS; Matin SF; Garcia M; Fang D; Wang TY; Yu W; Gong K; Song Y; He ZS; He Q; Zhou LQ
    BJU Int; 2013 Nov; 112(7):917-24. PubMed ID: 23905945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of concomitant variant histology on the prognosis of patients with upper urinary tract urothelial carcinoma after radical nephroureterectomy.
    Shibing Y; Turun S; Qiang W; Junhao L; Haichao Y; Shengqiang Q; Ping H; Dehong C
    Urol Oncol; 2015 May; 33(5):204.e9-16. PubMed ID: 25800374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of Intravesical Recurrence After Ureteroscopic Biopsy for Upper Tract Urothelial Carcinoma: Does the Location Matter?
    Yoo S; You D; Song C; Hong B; Hong JH; Kim CS; Ahn H; Jeong IG
    J Endourol; 2017 Mar; 31(3):259-265. PubMed ID: 27785917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ureteroscope can assist risk stratification in upper tract urothelial carcinoma].
    Ma RZ; Qiu M; He W; Yang B; Xia HZ; Zou D; Lu M; Ma LL; Lu J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Aug; 49(4):632-637. PubMed ID: 28816279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
    Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic indicators for upper tract urothelial carcinoma after radical nephroureterectomy: the impact of lymphovascular invasion.
    Godfrey MS; Badalato GM; Hruby GW; Razmjoo M; McKiernan JM
    BJU Int; 2012 Sep; 110(6):798-803. PubMed ID: 22313599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laparoscopic versus open nephroureterectomy to treat localized and/or locally advanced upper tract urothelial carcinoma: oncological outcomes from a multicenter study.
    Liu JY; Dai YB; Zhou FJ; Long Z; Li YH; Xie D; Liu B; Tang J; Tan J; Yao K; He LY
    BMC Surg; 2017 Jan; 17(1):8. PubMed ID: 28095848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma.
    Tanaka N; Kikuchi E; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakamura S; Oya M
    BJU Int; 2013 May; 111(6):857-64. PubMed ID: 22757942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The characteristics of recurrent upper tract urothelial carcinoma after radical nephroureterectomy without bladder cuff excision.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Yonsei Med J; 2015 Mar; 56(2):375-81. PubMed ID: 25683984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of tumor architecture on disease recurrence and cancer-specific mortality of upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Fan B; Hu B; Yuan Q; Wen S; Liu T; Bai S; Qi X; Wang X; Yang D; Sun X; Song X
    Tumour Biol; 2017 Jul; 39(7):1010428317710822. PubMed ID: 28714362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study.
    Nakagawa T; Komemushi Y; Kawai T; Otsuka M; Miyakawa J; Uemura Y; Kanatani A; Taguchi S; Naito A; Suzuki M; Nishimatsu H; Hirano Y; Tanaka Y; Matsumoto A; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
    World J Urol; 2017 Oct; 35(10):1569-1575. PubMed ID: 28397000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term endoscopic management of upper tract urothelial carcinoma: 20-year single-centre experience.
    Cutress ML; Stewart GD; Wells-Cole S; Phipps S; Thomas BG; Tolley DA
    BJU Int; 2012 Dec; 110(11):1608-17. PubMed ID: 22564677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical, ureteroscopic and photodynamic diagnosis of urothelial carcinomas of the upper tract: state-of-the art review for the yearly scientific report of the French National Association of Urology].
    Nison L; Bozzini G; Rouprêt M; Traxer O; Colin P
    Prog Urol; 2014 Nov; 24(15):977-86. PubMed ID: 25199724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of renal function after nephroureterectomy in patients with upper tract urothelial carcinoma.
    Hashimoto T; Ohno Y; Nakashima J; Gondo T; Nakagami Y; Namiki K; Horiguchi Y; Yoshioka K; Ohori M; Tachibana M
    Jpn J Clin Oncol; 2015 Nov; 45(11):1064-8. PubMed ID: 26355160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Cha EK; Shariat SF; Kormaksson M; Novara G; Chromecki TF; Scherr DS; Lotan Y; Raman JD; Kassouf W; Zigeuner R; Remzi M; Bensalah K; Weizer A; Kikuchi E; Bolenz C; Roscigno M; Koppie TM; Ng CK; Fritsche HM; Matsumoto K; Walton TJ; Ehdaie B; Tritschler S; Fajkovic H; Martínez-Salamanca JI; Pycha A; Langner C; Ficarra V; Patard JJ; Montorsi F; Wood CG; Karakiewicz PI; Margulis V
    Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.
    Yafi FA; Novara G; Shariat SF; Gupta A; Matsumoto K; Walton TJ; Fritsche HM; El-Hakim A; Trischler S; Martínez-Salamanca JI; Seitz C; Ficarra V; Zattoni F; Karakiewicz PI; Kassouf W
    BJU Int; 2012 Jul; 110(2 Pt 2):E7-13. PubMed ID: 22177329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent.
    Mbeutcha A; Lucca I; Margulis V; Karam JA; Wood CG; de Martino M; Mathieu R; Haitel A; Xylinas E; Kluth L; Rouprêt M; Karakiewicz PI; Briganti A; Rink M; Rieken M; Weizer AZ; Raman JD; Rioux-Leclecq N; Bolenz C; Bensalah K; Lotan Y; Seitz C; Remzi M; Shariat SF; Klatte T
    World J Urol; 2016 Aug; 34(8):1155-61. PubMed ID: 26658888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A contemporary review of management and prognostic factors of upper tract urothelial carcinoma.
    Leow JJ; Orsola A; Chang SL; Bellmunt J
    Cancer Treat Rev; 2015 Apr; 41(4):310-9. PubMed ID: 25736461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.